Insider filing · RCUS

Jennifer Jarrett sold $751K of Arcus Biosciences (RCUS)

Executed Oct 6 2025, disclosed Oct 8 2025, 2 days later.

Returns are measured on stock purchases only.

JJ Jennifer Jarrett Director, President and CEO profile →

Jennifer Jarrett (Director, President and CEO) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Arcus Biosciences, Inc. (RCUS). Across 1 priced purchase filing, the average 21-session return was +1.4% from execution and +0.0% from disclosure (delay-adjusted; derived). The largest single filing was $467K of RCUS (21,208 sh across 2 lots, as filed), executed Dec 16 2025.

RCUS Arcus Biosciences, Inc. RCUS · Healthcare · 21 filings in 24 months ticker →

Healthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→